Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.7M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
13.6M
-
Shares change
-
+197K
-
Total reported value, excl. options
-
$22.2M
-
Value change
-
+$52K
-
Put/Call ratio
-
2.78
-
Number of buys
-
49
-
Number of sells
-
-38
-
Price
-
$1.63
Significant Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) as of Q1 2025
122 filings reported holding INO - INOVIO PHARMACEUTICALS, INC. - Common Stock as of Q1 2025.
INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.6M shares
of 52.7M outstanding shares and own 25.82% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (3.12M shares), BlackRock, Inc. (2.32M shares), VANGUARD GROUP INC (2.03M shares), BANK OF AMERICA CORP /DE/ (1.3M shares), GEODE CAPITAL MANAGEMENT, LLC (847K shares), Stonepine Capital Management, LLC (518K shares), STATE STREET CORP (514K shares), NORTHERN TRUST CORP (466K shares), MORGAN STANLEY (285K shares), and UBS Group AG (208K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.